Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
66
BCRX Quote, Financials, Valuation and Earnings
Last price:
$7.70
Seasonality move
:
3.63%
Day range:
$7.47 - $7.76
52-week range:
$6.00 - $11.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.77x
P/B ratio:
--
Volume:
2.1M
Avg. volume:
3.9M
1-year change:
0.39%
Market cap:
$1.6B
Revenue:
$450.7M
EPS (TTM):
-$0.05
Earnings Data
Next earnings date for BCRX
Feb 23
2026
Most recent earnings per share
$0.06
Missed by $0.01
(Nov 3/2025)
Consensus Estimate
$0.07
(Nov 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BCRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/23/2026 | Q4 | $150M | -- | -- | $0.03 | -- |
| 11/03/2025 | Q3 | $163M | $159.4M | $0.06 | $0.07 | -$0.01 |
| 08/04/2025 | Q2 | $149.8M | $163.4M | $0.02 | $0.03 | -$0.00 |
| 05/05/2025 | Q1 | $127.8M | $145.5M | $0.00 | -$0.05 | $0.05 |
| 02/24/2025 | Q4 | $130M | $131.5M | -$0.13 | -$0.06 | -$0.07 |
| 11/04/2024 | Q3 | $112.7M | $117.1M | -$0.07 | -$0.08 | $0.02 |
| 08/05/2024 | Q2 | $98.3M | $109.3M | -$0.06 | -$0.16 | $0.10 |
| 05/06/2024 | Q1 | $85.5M | $92.8M | -$0.17 | -$0.23 | $0.06 |
| 02/26/2024 | Q4 | $90M | $93.4M | -$0.31 | -$0.22 | -$0.08 |
| 11/02/2023 | Q3 | -- | $86.7M | -$0.19 | -- | -- |
| 08/03/2023 | Q2 | -- | $82.5M | -$0.40 | -- | -- |
| 05/03/2023 | Q1 | -- | $68.8M | -$0.28 | -- | -- |
| 02/21/2023 | Q4 | -- | $79.5M | -$0.38 | -- | -- |
| 11/01/2022 | Q3 | -- | $75.8M | -$0.23 | -- | -- |
| 08/04/2022 | Q2 | -- | $65.5M | -$0.32 | -- | -- |
| 05/05/2022 | Q1 | -- | $49.9M | -$0.40 | -- | -- |
| 02/23/2022 | Q4 | -- | $47.2M | -$0.10 | -- | -- |
| 11/03/2021 | Q3 | -- | $41M | -$0.33 | -- | -- |
| 08/05/2021 | Q2 | -- | $50M | -$0.24 | -- | -- |
| 05/06/2021 | Q1 | -- | $19.1M | -$0.36 | -- | -- |
| 02/25/2021 | Q4 | -- | $4M | -$0.34 | -- | -- |
| 11/05/2020 | Q3 | -- | $6.1M | -$0.26 | -- | -- |
| 08/06/2020 | Q2 | -- | $2.9M | -$0.24 | -- | -- |
| 05/06/2020 | Q1 | -- | $4.8M | -$0.24 | -- | -- |
| 03/05/2020 | Q4 | -- | $39.7M | -$0.02 | -- | -- |
| 11/06/2019 | Q3 | -- | $1.8M | -$0.34 | -- | -- |
| 08/06/2019 | Q2 | -- | $1.4M | -$0.34 | -- | -- |
| 05/08/2019 | Q1 | -- | $5.9M | -$0.28 | -- | -- |
| 03/04/2019 | Q4 | -- | $2.7M | -$0.25 | -- | -- |
| 11/06/2018 | Q3 | -- | $1.5M | -$0.28 | -- | -- |
| 08/07/2018 | Q2 | -- | $12.5M | -$0.19 | -- | -- |
| 05/08/2018 | Q1 | -- | $4M | -$0.26 | -- | -- |
| 02/27/2018 | Q4 | -- | $3.9M | -$0.20 | -- | -- |
| 11/07/2017 | Q3 | -- | $8.8M | -$0.18 | -- | -- |
| 08/07/2017 | Q2 | -- | $3.1M | -$0.21 | -- | -- |
| 05/04/2017 | Q1 | -- | $9.4M | -$0.19 | -- | -- |
| 02/27/2017 | Q4 | -- | $9M | -$0.06 | -- | -- |
| 11/07/2016 | Q3 | -- | $7.8M | -$0.16 | -- | -- |
| 08/04/2016 | Q2 | -- | $4.8M | -$0.22 | -- | -- |
| 05/05/2016 | Q1 | -- | $4.8M | -$0.31 | -- | -- |
| 02/23/2016 | Q4 | -- | -- | -- | -- | -- |
BioCryst Pharmaceuticals, Inc. Earnings Questions
-
How Much did BioCryst Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
BioCryst Pharmaceuticals, Inc. reported $159.4M worth of top line sales in its most recent quarter.
-
Did BioCryst Pharmaceuticals, Inc. Beat Earnings Last Quarter?
BioCryst Pharmaceuticals, Inc. announced earnings per share of $0.06 which represents a miss of analyst forecast a $0.07 per share.
-
Is BioCryst Pharmaceuticals, Inc. Profitable?
BioCryst Pharmaceuticals, Inc. reported $156.9M that represents $0.71 per share over the last quarter.
-
What is the Analyst Consensus for BioCryst Pharmaceuticals, Inc. EPS Next Year?
BioCryst Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$0.43 per share to -$0.36 per share next year representing a decrease of -87.4%.
-
When is BioCryst Pharmaceuticals, Inc.'s Earnings Date?
BioCryst Pharmaceuticals, Inc.'s next earnings date is February 23, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
